Stay updated on Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Sign up to get notified when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator has been updated from v3.5.0 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-26T15:19:18.000Z thumbnail image
  4. Check
    53 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.3 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-21T20:05:35.000Z thumbnail image
  5. Check
    68 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3. The page now displays Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-07T07:53:12.000Z thumbnail image
  6. Check
    89 days ago
    Change Detected
    Summary
    Revision history updated from v3.4.1 to v3.4.2; no user-facing content or functional changes are evident.
    Difference
    0.1%
    Check dated 2026-02-13T16:54:06.000Z thumbnail image
  7. Check
    96 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no study content or data appear to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-06T11:32:25.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page.
    Difference
    0.1%
    Check dated 2026-02-05T13:31:35.000Z thumbnail image

Stay in the know with updates to Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Comparing Ocrelizumab and Ofatumumab in MS Clinical Trial page.